Jintropin AQ is a synthetic human growth hormone (HGH) that is used to treat various growth-related disorders. It contains recombinant human growth hormone that mimics the effects of the natural growth hormone production in the body. Jintropin AQ is administered via injection and provides benefits such as improved muscle mass, bone density, mental clarity, and energy levels. The medication is commonly used to treat pediatric and adult patients with growth hormone deficiency (GHD) and other conditions that result in reduced levels of HGH.
Indication:
Jintropin AQ is indicated for the treatment of GHD in both adults and children. In children, it is used to treat growth failure due to inadequate HGH secretion, as well as for conditions such as Turner Syndrome, Prader-Willi Syndrome, and chronic renal insufficiency. In adults, Jintropin AQ is used for the treatment of adult-onset GHD, which can result from pituitary or hypothalamic tumors, radiation therapy, or trauma.
Mechanism of Action:
Jintropin AQ contains recombinant human growth hormone, which stimulates the production of insulin-like growth factor-1 (IGF-1) in the liver and peripheral tissues. IGF-1 promotes bone and muscle growth, cell development and regeneration, and metabolic processes such as lipid metabolism. Jintropin AQ also promotes the breakdown of triglycerides and the use of fats as an energy source, leading to reduced body fat and improved muscle-to-fat ratio.
Benefits:
Jintropin AQ provides the following benefits to individuals with GHD:
1. Increased Muscle Mass and Strength: Jintropin AQ increases muscle mass and strength, helping individuals improve their physical performance and recovery.
2. Improved Bone Density: Improved bone density reduces the risk of fractures and bone-related injuries.
3. Higher Energy Levels: Jintropin AQ also increases energy levels and enhances overall performance, reducing fatigue and weakness.
4. Mental Clarity: Jintropin AQ has been shown to improve clarity of thought, memory, and cognitive functioning.
5. Reduced Body Fat: Jintropin AQ decreases body fat and improves body composition, resulting in a leaner, more muscular physique.
How to Use:
Jintropin AQ is administered via injection, either by a healthcare provider or self-administration with proper instruction. The injection is usually given subcutaneously (under the skin) in the abdomen, thigh, or buttocks. The injection site must be changed each time to avoid tissue damage.
Administration:
Jintropin AQ is available in a prefilled cartridge and the solution for injection needs to be reconstituted before use. The cartridge should be stored in the refrigerator until use and should not be frozen or shaken excessively.
Dosage:
The dose of Jintropin AQ is dependent on the individual patient’s age, weight, and medical condition. In children, the dosage is typically 0.03-0.05 mg/kg/day, while in adults, the dosage may range from 0.1 to 0.2 mg/day. The administration schedule and dose should be adjusted according to the individual’s response, medical condition, and goal of treatment.
Efficacy:
Jintropin AQ is effective in treating GHD in children and adults. Pediatric patients treated with Jintropin AQ showed improved growth velocity, increased bone and muscle mass, and reduction in body fat. Adult patients treated with Jintropin AQ showed improved muscle mass, reduced body fat, increased energy levels, and improvement in quality of life.
Storage:
Jintropin AQ cartridge should be stored in the refrigerator between 2°C to 8°C (36°F to 46°F). The cartridge should not be frozen and should not be exposed to direct sunlight. The reconstituted solution should not be frozen and should be used immediately or stored under refrigeration.
Side Effects:
Like all medications, Jintropin AQ may cause side effects in some individuals. The most common side effects include:
1. Injection site reactions such as pain, swelling, and redness.
2. Hypersensitivity reactions such as rash, hives, or itching.
3. Headache and nausea.
4. Fatigue and general weakness.
5. Edema (fluid accumulation) in the extremities.
6. Transient hyperglycemia (high blood sugar) may occur.
Precautions:
Jintropin AQ should be used with caution in patients with a history of pituitary tumors, diabetes, or cancer. The medication should not be used during pregnancy or breastfeeding, as its effects on fetal development and lactation are unknown. Patients should be monitored for signs of excessive growth, as this can lead to joint pain and other complications.
Contraindications:
Jintropin AQ should not be used in patients with a history of hypersensitivity to any of its components. It should not be used in patients with an ongoing malignant disease, as there have been reports of growth hormone stimulating tumor growth in some cases. Patients with active malignancy should not receive treatment with Jintropin AQ.
Reviews
There are no reviews yet.